These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11298537)

  • 1. First experience of topical SDZ ASM 981 in children with atopic dermatitis.
    Harper J; Green A; Scott G; Gruendl E; Dorobek B; Cardno M; Burtin P
    Br J Dermatol; 2001 Apr; 144(4):781-7. PubMed ID: 11298537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis.
    Luger T; Van Leent EJ; Graeber M; Hedgecock S; Thurston M; Kandra A; Berth-Jones J; Bjerke J; Christophers E; Knop J; Knulst AC; Morren M; Morris A; Reitamo S; Roed-Petersen J; Schoepf E; Thestrup-Pedersen K; Van Der Valk PG; Bos JD
    Br J Dermatol; 2001 Apr; 144(4):788-94. PubMed ID: 11298538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis.
    Van Leent EJ; Gräber M; Thurston M; Wagenaar A; Spuls PI; Bos JD
    Arch Dermatol; 1998 Jul; 134(7):805-9. PubMed ID: 9681343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients.
    Allen BR; Lakhanpaul M; Morris A; Lateo S; Davies T; Scott G; Cardno M; Ebelin ME; Burtin P; Stephenson TJ
    Arch Dis Child; 2003 Nov; 88(11):969-73. PubMed ID: 14612358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K; Jarvis B
    Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on topical pimecrolimus in atopic dermatitis.
    Wellington K; Jarvis B
    Am J Clin Dermatol; 2002; 3(6):435-8. PubMed ID: 12113651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981.
    Neckermann G; Bavandi A; Meingassner JG
    Br J Dermatol; 2000 Apr; 142(4):669-79. PubMed ID: 10792216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study.
    Queille-Roussel C; Paul C; Duteil L; Lefebvre MC; Rapatz G; Zagula M; Ortonne JP
    Br J Dermatol; 2001 Mar; 144(3):507-13. PubMed ID: 11260007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood concentrations, tolerability and efficacy of pimecrolimus cream 1% in Japanese infants and children with atopic dermatitis.
    Eichenfield LF; Ho V; Matsunaga J; Leclerc P; Paul C; Hanifin JM
    J Dermatol; 2007 Apr; 34(4):231-6. PubMed ID: 17352719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study.
    Meurer M; Fölster-Holst R; Wozel G; Weidinger G; Jünger M; Bräutigam M;
    Dermatology; 2002; 205(3):271-7. PubMed ID: 12399676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
    Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
    Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascomycins: promising agents for the treatment of inflammatory skin diseases.
    Paul C; Graeber M; Stuetz A
    Expert Opin Investig Drugs; 2000 Jan; 9(1):69-77. PubMed ID: 11060661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Tacrolimus versus Hydrocortisone on Atopic Dermatitis in Paediatric Patients: A Randomized Controlled Trial.
    Rahman MF; Nandi AK; Kabir S; Kamal M; Basher MS; Banu LA
    Mymensingh Med J; 2015 Jul; 24(3):457-63. PubMed ID: 26329939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occlusive treatment of chronic hand dermatitis with pimecrolimus cream 1% results in low systemic exposure, is well tolerated, safe, and effective. An open study.
    Thaçi D; Steinmeyer K; Ebelin ME; Scott G; Kaufmann R
    Dermatology; 2003; 207(1):37-42. PubMed ID: 12835546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis.
    Van Leent EJ; Ebelin ME; Burtin P; Dorobek B; Spuls PI; Bos JD
    Dermatology; 2002; 204(1):63-8. PubMed ID: 11834853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.